コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 be a biomarker of synaptic density (e.g., in neurodegenerative disorders).
2 resident macrophages and a severe late-onset neurodegenerative disorder.
3 ay of symptomatic therapy for this incurable neurodegenerative disorder.
4 o Alzheimer disease as the most common human neurodegenerative disorder.
5 le system atrophy (MSA) is a sporadic orphan neurodegenerative disorder.
6 of Alzheimer disease (AD), the most frequent neurodegenerative disorder.
7 on disease (HD) is the most common inherited neurodegenerative disorder.
8 ause Friedreich's ataxia (FRDA), a recessive neurodegenerative disorder.
9 on's Disease (PD) is an age-related, chronic neurodegenerative disorder.
10 's disease (PD) is a chronic and progressive neurodegenerative disorder.
11 Alzheimer's disease (AD), the most prevalent neurodegenerative disorder.
12 tington's disease, and potentially for other neurodegenerative disorders.
13 ent therapeutic target for acute and chronic neurodegenerative disorders.
14 ay contribute to pathogenesis in a subset of neurodegenerative disorders.
15 lies is a major factor in the progression of neurodegenerative disorders.
16 ted in disease states ranging from asthma to neurodegenerative disorders.
17 fe therapeutic strategy for the treatment of neurodegenerative disorders.
18 certain diseases, including brain tumors and neurodegenerative disorders.
19 al navigation, with a particular emphasis on neurodegenerative disorders.
20 r prostate cancer, sudden cardiac arrest and neurodegenerative disorders.
21 -induced neuronal damage during aging and in neurodegenerative disorders.
22 phological perturbations are associated with neurodegenerative disorders.
23 utamate uptake is a core feature of multiple neurodegenerative disorders.
24 rategic design of therapeutic approaches for neurodegenerative disorders.
25 h frontotemporal dementia (IBMPFD) and other neurodegenerative disorders.
26 ing of neuroinflammation in a broad range of neurodegenerative disorders.
27 both learning and memory and the etiology of neurodegenerative disorders.
28 ing stress (proteotoxicity), the hallmark of neurodegenerative disorders.
29 est a possible etiological mechanism in some neurodegenerative disorders.
30 t mitostasis are significant contributors to neurodegenerative disorders.
31 s have been implicated in SMA as in in other neurodegenerative disorders.
32 s, such as cancers, metabolic syndromes, and neurodegenerative disorders.
33 us maladies that range from heart disease to neurodegenerative disorders.
34 in EB regulation, which might be impaired in neurodegenerative disorders.
35 ology in Huntington's disease (HD) and other neurodegenerative disorders.
36 of postsynaptic aberrations associated with neurodegenerative disorders.
37 tructured amyloid fibrils are linked to many neurodegenerative disorders.
38 and its association with the pathogenesis of neurodegenerative disorders.
39 ison of synaptic transmission alterations in neurodegenerative disorders.
40 mmon focus of several neurodevelopmental and neurodegenerative disorders.
41 function of adult tissues which can lead to neurodegenerative disorders.
42 might provide benefit for those afflicted by neurodegenerative disorders.
43 sess the microglial phagocytic efficiency in neurodegenerative disorders.
44 standing the pathogenesis and progression of neurodegenerative disorders.
45 ajor risk factor in many forms of late-onset neurodegenerative disorders.
46 nic repeat sequences in multiple untreatable neurodegenerative disorders.
47 ction in PD, which may be relevant for other neurodegenerative disorders.
48 setting to study P2X7R expression levels in neurodegenerative disorders.
49 nto the brains of patients with two distinct neurodegenerative disorders.
50 rial dysfunction in cancer and metabolic and neurodegenerative disorders.
51 ributes to cognitive decline associated with neurodegenerative disorders.
52 a diagnostic tool for AD and possibly other neurodegenerative disorders.
53 hin and between brain areas is a hallmark of neurodegenerative disorders.
54 dition that has a significant impact in many neurodegenerative disorders.
55 of different pathologies such as leukemia or neurodegenerative disorders.
56 sion and fission have been linked to various neurodegenerative disorders.
57 ith patient-specific medicine approaches for neurodegenerative disorders.
58 lded proteins in the brain occurs in several neurodegenerative disorders.
59 to understand movement selection deficits in neurodegenerative disorders.
60 es ranging from cancer to cardiovascular and neurodegenerative disorders.
61 losely linked to the pathogenesis of several neurodegenerative disorders.
62 ncentrations have been identified in several neurodegenerative disorders.
63 and may provide targets for intervention in neurodegenerative disorders.
64 ective mechanisms previously associated with neurodegenerative disorders.
65 trategy may be applicable to a wide range of neurodegenerative disorders.
66 been implicated in pathology of AD and other neurodegenerative disorders.
67 r interrogating decision-making processes in neurodegenerative disorders.
68 umerous neurodevelopmental, psychiatric, and neurodegenerative disorders.
69 tegration of neuronal networks, resulting in neurodegenerative disorders.
70 mpairment in Parkinson's disease and related neurodegenerative disorders.
71 echanism underlying the pathogenesis of many neurodegenerative disorders.
72 olved in the tau pathology in AD and related neurodegenerative disorders.
73 s defining the role of protein misfolding in neurodegenerative disorders.
74 ing of the connection between PNN damage and neurodegenerative disorders.
75 ostasis but lose homeostatic function during neurodegenerative disorders.
76 R-12 to be a potential therapeutic agent for neurodegenerative disorders.
77 amosa should be considered a risk factor for neurodegenerative disorders.
78 al determinant in the progression of several neurodegenerative disorders.
79 as previously been implicated in an array of neurodegenerative disorders.
80 dation have been implicated in several human neurodegenerative disorders.
81 as well as susceptibility to autoimmune and neurodegenerative disorders.
82 s at the core of a number of psychiatric and neurodegenerative disorders.
83 ancer, cardiovascular disease, diabetes, and neurodegenerative disorders.
84 hanisms common to human cerebral malaria and neurodegenerative disorders.
85 lzheimer's disease (AD), as well as in other neurodegenerative disorders.
86 r which dysfunction has been associated with neurodegenerative disorders.
87 genic proteins is a pathological hallmark of neurodegenerative disorders.
88 k of significant disease-modifying drugs for neurodegenerative disorders, a pressing need for new che
89 nson disease is a debilitating and incurable neurodegenerative disorder affecting approximately 1-2%
91 ty of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making t
93 Because of the multifactorial nature of this neurodegenerative disorder and its complex relationship
94 lzheimer disease (AD) is a common and lethal neurodegenerative disorder and many germline inherited v
95 Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the main cause of dementi
96 T: Alzheimer's disease (AD) is a devastating neurodegenerative disorder and there are currently no ef
97 de (NR), protects against metabolic disease, neurodegenerative disorders and age-related physiologica
99 r treating diverse human diseases, including neurodegenerative disorders and infectious diseases.
100 (alphaS) inclusions are found in a number of neurodegenerative disorders and is a hallmark feature of
101 approaches in patients with brain traumas or neurodegenerative disorders and preserve neural stem cel
102 tential treatment strategy for several major neurodegenerative disorders and suggests that alteration
104 ease (HD) is an autosomal dominant inherited neurodegenerative disorder, and no cure is available cur
105 's disease (PD) is the second most diagnosed neurodegenerative disorder, and the classic motor sympto
106 dopamine can be correlated with a number of neurodegenerative disorders, and as such, in vivo analys
107 be used for testing potential treatments for neurodegenerative disorders, and identifies GCase as a c
108 Microglial activation is a hallmark of most neurodegenerative disorders, and is particularly conspic
109 the death of neurons and oligodendrocytes in neurodegenerative disorders, and provide opportunities f
110 h mechanisms are altered during aging and in neurodegenerative disorders, and the potential applicati
117 are known to cause 10 late-onset progressive neurodegenerative disorders as the repeats expand beyond
118 em, which is the usual clinical profile of a neurodegenerative disorder associated to the Parkinson's
119 sler-Scheinker disease (GSS) is an inherited neurodegenerative disorder associated with mutations in
120 : Creutzfeldt-Jakob disease (CJD) is a fatal neurodegenerative disorder associated with the accumulat
123 inhibition is a promising strategy to treat neurodegenerative disorders, but the development of nNOS
124 Advanced age is the greatest risk factor for neurodegenerative disorders, but the mechanisms that ren
125 e the association between glaucoma and other neurodegenerative disorders by investigating glaucoma-as
128 is hypothesis to our understanding of common neurodegenerative disorders can suggest new therapeutic
129 gton's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG expansion in
131 (HD) is a dominantly inherited, progressive neurodegenerative disorder caused by a CAG repeat expans
132 Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG trinucleotide
133 sociated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a limited expansion
135 Spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disorder caused by a polyglutamine-enc
137 on's disease (HD) is a progressive and fatal neurodegenerative disorder caused by an expanded CAG rep
140 Huntington's disease (HD) is a heritable neurodegenerative disorder caused by expansion of CAG (g
141 disease (AD) is a genetically heterogeneous neurodegenerative disorder caused by fully penetrant sin
142 Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused by mutations in NPC1 o
143 linked adrenoleukodystrophy is a devastating neurodegenerative disorder caused by mutations in the AB
145 gton's disease (HD) is an autosomal-dominant neurodegenerative disorder caused by the expansion of a
146 Huntington disease (HD) is an autosomal neurodegenerative disorder caused by the expansion of Po
147 hies (TSEs), are a group of rare progressive neurodegenerative disorders caused by an abnormally fold
148 d Parkinson disease, are rapidly progressive neurodegenerative disorders caused by misfolding followe
149 ly required to cure several common and fatal neurodegenerative disorders caused by protein misfolding
150 gton's disease (HD) is an autosomal dominant neurodegenerative disorder characterised by a triad of m
151 ltiple system atrophy (MSA) is a progressive neurodegenerative disorder characterised by a variable c
153 degeneration (AMD) is a progressive retinal neurodegenerative disorder characterized by extracellula
154 ilies with a childhood- or adolescence-onset neurodegenerative disorder characterized by gait abnorma
155 wo unrelated families each with an infantile neurodegenerative disorder characterized by loss of deve
156 r of Parkinson's disease (PD), a progressive neurodegenerative disorder characterized by loss of dopa
157 Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by pathological
163 Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by the accumula
164 Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of
166 Expanded CAG repeats lead to debilitating neurodegenerative disorders characterized by aggregation
167 mporal dementia (FTD) encompasses a group of neurodegenerative disorders characterized by cognitive a
168 iseases are a group of progressive and fatal neurodegenerative disorders characterized by deposition
169 for gene therapy, including the treatment of neurodegenerative disorders characterized by pathologica
170 and Multiple System Atrophy are age-related neurodegenerative disorders characterized by progressive
171 lusions is linked to a number of devastating neurodegenerative disorders collectively known as tauopa
172 play a causative role in the pathogenesis of neurodegenerative disorders, critically modulating the e
173 paraplegia, a highly heterogeneous group of neurodegenerative disorders defined by progressive neuro
174 s shedding light on the role of lysosomes in neurodegenerative disorders, demonstrating how insights
175 tion contributes to pathogenesis in multiple neurodegenerative disorders, determining its mechanistic
176 s in Huntington's disease (HD), a late-onset neurodegenerative disorder due to a toxic dominant gain-
177 ral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder due to selective loss of moto
178 wedish BioFINDER (Biomarkers for Identifying Neurodegenerative Disorders Early and Reliably) cohort (
179 Genetic defects in DNA repair underlie other neurodegenerative disorders (eg, ataxia-telangiectasia),
180 Idiopathic Parkinson disease is a common neurodegenerative disorder for which misdiagnosis occurs
182 to broadly understanding the pathogenesis of neurodegenerative disorders, for monitoring their progre
184 ular histopathology at the cellular level in neurodegenerative disorders frequently appears at odds w
186 of Huntington's disease (HD), a devastating neurodegenerative disorder, how proteasome activity is r
187 the autophagy pathway have been observed in neurodegenerative disorders; however, no genetically-inh
190 MENT Parkinson's disease (PD) is a prevalent neurodegenerative disorder in the aging population.
191 hic lateral sclerosis (ALS) is a devastating neurodegenerative disorder in which the loss of upper an
192 ) and similar dementias are common incurable neurodegenerative disorders in the aging population.
193 ventriculomegalic presentations of selected neurodegenerative disorders in which benefits from shunt
194 mporal dementia (FTD) are overlapping, fatal neurodegenerative disorders in which the molecular and p
195 eptor expression is associated with numerous neurodegenerative disorders including Alzheimer disease
196 n is involved in the pathogenesis of several neurodegenerative disorders including Alzheimer's diseas
197 are also involved in the etiopathogenesis of neurodegenerative disorders including certain forms of d
198 TMEM106B are associated with several common neurodegenerative disorders including frontotemporal lob
200 ide repeat (TNR) expansion underlies several neurodegenerative disorders including Huntington's disea
201 function is one of the major contributors to neurodegenerative disorders including Parkinson disease.
202 gregation underlies a variety of age-related neurodegenerative disorders, including Alzheimer's and P
203 synuclein is commonly observed in a range of neurodegenerative disorders, including Alzheimer's and P
204 ational modification associated with several neurodegenerative disorders, including Alzheimer's and P
205 Amyloid fibrils are a hallmark of a range of neurodegenerative disorders, including Alzheimer's and P
207 e brain tissue of patients with a variety of neurodegenerative disorders, including Alzheimer's disea
208 -Hakola disease and associated with multiple neurodegenerative disorders, including Alzheimer's disea
209 in tauopathies [1]: age-related progressive neurodegenerative disorders, including Alzheimer's disea
210 euronal death in currently untreatable human neurodegenerative disorders, including Alzheimer's disea
211 nt kinase 5 (Cdk5), which is associated with neurodegenerative disorders, including Alzheimer's disea
212 PSD95 levels are diminished in ageing and neurodegenerative disorders, including Alzheimer's disea
213 otein tau is strongly implicated in multiple neurodegenerative disorders, including frontotemporal de
214 with neuropathological inclusions in several neurodegenerative disorders, including frontotemporal lo
217 Lewy bodies, have been linked to a range of neurodegenerative disorders, including Parkinson's disea
218 ions of people globally are at high risk for neurodegenerative disorders, infertility or having child
219 in connectivity has been assessed in several neurodegenerative disorders investigating the mutual cor
221 he treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple s
223 enetic factors in the pathogenesis of common neurodegenerative disorders, it is critical that mechani
225 orea-acanthocytosis is one of the hereditary neurodegenerative disorders known as the neuroacanthocyt
226 ociated protein, cause a subtype of familial neurodegenerative disorder, known as frontotemporal loba
227 hologies, such as diabetic complications and neurodegenerative disorders like Alzheimer's and Parkins
228 s cellular processes and it is implicated in neurodegenerative disorders, like Alzheimer disease.
229 hic lateral sclerosis (ALS) is a progressive neurodegenerative disorder marked by the loss of motor n
233 Huntington's disease (HD) is an inherited neurodegenerative disorder of which skeletal muscle atro
234 ase that shares many similarities with other neurodegenerative disorders of the central nervous syste
235 brids is linked to various human cancers and neurodegenerative disorders, our study raises the possib
238 r Sanfilippo disease type A is a progressive neurodegenerative disorder presenting in early childhood
239 NCLs) are a group of inherited and incurable neurodegenerative disorders primarily afflicting the ped
240 ways in glaucoma that overlap with other CNS neurodegenerative disorders promises to provide renewed
241 Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like t
243 nganese (Mn) causes manganism, a progressive neurodegenerative disorder similar to idiopathic Parkins
244 sult in a number of diseases such as cancer, neurodegenerative disorders, stroke and myocardial infar
245 nce of an AUG start codon and contributes to neurodegenerative disorders such as ALS and fragile X-as
246 roteotoxicity associated with age-associated neurodegenerative disorders such as Alzheimer and Parkin
247 proteins play a crucial role in a variety of neurodegenerative disorders such as Alzheimer's and Park
248 of age-associated proteinopathies, including neurodegenerative disorders such as Alzheimer's and Park
249 the early diagnosis and treatment of several neurodegenerative disorders such as Alzheimer's disease
250 l morphology contributes to the pathology of neurodegenerative disorders such as Alzheimer's disease
251 urodevelopmental disorders such as autism to neurodegenerative disorders such as Alzheimer's disease
252 evels result in apoptosis and are evident in neurodegenerative disorders such as Alzheimer's disease
253 ions may mitigate the progression of chronic neurodegenerative disorders such as Alzheimer's disease
255 ough FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease,
256 nding of the influence of innate immunity on neurodegenerative disorders such as Alzheimer's disease,
257 d insulin/IGF-1) have been reported in other neurodegenerative disorders such as Alzheimer's disease.
258 disorders such as autism spectrum disorders; neurodegenerative disorders such as Alzheimer's disease;
259 ve of the more chronic nature of progressive neurodegenerative disorders such as Parkinson's disease
261 in a voxel, which is expected to increase in neurodegenerative disorders such as Parkinson's disease.
262 Srxn1 may represent a therapeutic target for neurodegenerative disorders such as PD that involve nitr
264 n aggregation is associated with age-related neurodegenerative disorders, such as Alzheimer's and pol
265 igomeric forms of amyloid proteins linked to neurodegenerative disorders, such as amyloid-beta (Abeta
266 stitute a novel approach to treating various neurodegenerative disorders, such as FTD and Alzheimer's
267 loid fibrils, which is related to a range of neurodegenerative disorders, such as Parkinson's and Alz
269 Huntington's disease (HD) is an inherited neurodegenerative disorder that affects one in every 10,
270 Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is currently without a c
272 trophic Lateral Sclerosis (ALS) is a complex neurodegenerative disorder that may have anterior visual
273 ent of Niemann Pick Type C-1 (NPC1), a fatal neurodegenerative disorder that stems from abnormal chol
277 (HSPs) are a rare and heterogeneous group of neurodegenerative disorders that are clinically characte
278 TSEs) or prion diseases are a group of fatal neurodegenerative disorders that include Kuru, Creutzfel
280 Alzheimer's disease (AD) is a prevalent neurodegenerative disorder triggered by the accumulation
281 identified mutations in human AIFM1 lead to neurodegenerative disorders varying in severity and onse
283 sease, dementia with Lewy bodies and genetic neurodegenerative disorders were alternative diagnoses i
284 s identified pathways associated with common neurodegenerative disorders when gene expression means w
285 son's disease (PD) is one of the most common neurodegenerative disorders, which progresses slowly whi
286 rontotemporal dementia (FTD) are overlapping neurodegenerative disorders whose pathogenesis remains l
287 sclerosis (ALS) is a devastating adult-onset neurodegenerative disorder with a poor prognosis and a m
288 Frontotemporal dementia is a heterogeneous neurodegenerative disorder with around a third of cases
290 stem atrophy is a fatal sporadic adult-onset neurodegenerative disorder with no symptomatic or diseas
292 spastic paraplegias (HSPs) are heterogeneous neurodegenerative disorders with over 50 known causative
293 rontotemporal dementia (FTD) are age-related neurodegenerative disorders with shared genetic etiologi
295 at these mutations are associated with other neurodegenerative disorders with tau pathology, includin
296 PA) is a proposed treatment for RP and other neurodegenerative disorders, with a phase II trial for R
297 ORF72 gene has been associated with multiple neurodegenerative disorders, with particularly high prev
298 arkinson's disease is the second most common neurodegenerative disorder without effective treatment.
299 inson's disease (PD), the second most common neurodegenerative disorder worldwide, but the mechanisms
300 associated with the pathogenesis of several neurodegenerative disorders, yet the underlying molecula
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。